Longitudinal adherence to fecal occult blood testing impacts colorectal cancer screening quality

American Journal of Gastroenterology

Volumn 106, Issue 6, 2011, Pages 1125-1134

  Gellad, Ziad F ^a,b   Stechuchak, Karen M ^a   Fisher, Deborah A ^a,b   Olsen, Maren K ^a,b   McDuffie, Jennifer R ^a   Stbye, Truls ^b,c   Yancy Jr , William S ^a,b  

^a DURHAM VA MEDICAL CENTER   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c DUKE NUS MEDICAL SCHOOL   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BARIUM ENEMA; CANCER SCREENING; COLONOSCOPY; COLORECTAL CANCER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OCCULT BLOOD TEST; PATIENT COMPLIANCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SIGMOIDOSCOPY; UNITED STATES;

AGED; COHORT STUDIES; COLONOSCOPY; COLORECTAL NEOPLASMS; CROSS-SECTIONAL STUDIES; EARLY DETECTION OF CANCER; FEMALE; FOLLOW-UP STUDIES; GUIDELINE ADHERENCE; HOSPITALS, VETERANS; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; MULTIVARIATE ANALYSIS; NEEDS ASSESSMENT; OCCULT BLOOD; QUALITY OF HEALTH CARE; RETROSPECTIVE STUDIES; SIGMOIDOSCOPY; UNITED STATES;

EID: 79957986878     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2011.11     Document Type: Article

References (29)

1. Jemal A, Siegel R, Ward E et al. Cancer statistics, 2009. CA Cancer J Clin 2009; 59: 225-49.
2. Gellad ZF, Provenzale D. Colorectal cancer: national and international perspective on the burden of disease and public health impact. Gastroenterology 2010; 138: 2177-90.
3. Levin B, Lieberman DA, McFarland B et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology 2008; 134: 1570-95. (Pubitemid 351615355)
4. Hardcastle JD, Chamberlain JO, Robinson MH et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996; 348: 1472-7. (Pubitemid 26400242)
5. Kronborg O, Fenger C, Jorn O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996; 348: 1467-71. (Pubitemid 26400241)
6. Mandel JS, Bond JH, Church TR. Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med 1993; 328 : 1365-71. (Pubitemid 23131388)
7. Centers for Disease Control and Prevention (CDC). Use of colorectal cancer tests - United States, 2002, 2004, and 2006. MMWR Morb Mortal Wkly Rep 2008; 57: 253-8.
8. Schenck AP, Peacock SC, Klabunde CN et al. Trends in colorectal cancer test use in the Medicare population, 1998- 2005. Am J Prev Med 2009; 37: 1-7.
9. El-Serag HB, Petersen L, Hampel H et al. The use of screening colonoscopy for patients cared for by the Department of Veterans Affairs. Arch Intern Med 2006; 166: 2202-8. (Pubitemid 44748766)
10. U.S. Preventive Services Task Force. Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2008; 149: 627-37.
11. Rex DK, Johnson DA, Anderson JC et al. American College of Gastroenterology Guidelines for Colorectal Cancer Screening 2008. Am J Gastroenterol 2009; 104: 739-50.
12. HEDIS 2010: Health Plan Employer Data and Information Set. National Committee for Quality Assurance: Washington, DC, 2010. Accessed on 1 March 2010 at http://www.ncqa.org/tabid/1044/Default.aspx.
13. VA Office of Quality and Performance. FY 2010 VHA Performance Measurement System Technical Manual, 2010; available at: http://vaww.oqp.med. va.gov/programs/pm/performance.aspx; accessed 31 January 2011.
14. Yancy WS, McDuffie JR, Stechuchak KM et al. Obesity and receipt of clinical preventive services in veterans. Obesity 2010; 18 : 1827-35.
15. Zeber JE, Grazier KL, Valenstein M et al. Effect of a medication copayment increase in veterans with schizophrenia. Am J Manag Care 2007; 13: 335-46. (Pubitemid 46983130)
16. Quan H, Sundararajan V, Halfon P et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care 2005; 43: 1130-9. (Pubitemid 41587600)
17. Schneeweiss S, Wang PS, Avorn J et al. Improved comorbidity adjustment for predicting mortality in Medicare populations. Health Serv Res 2003; 38: 1103-20. (Pubitemid 37048302)
18. Department of Veteran Affairs Office of Quality and Performance: Performance Data Resource Center. Available at: http://vaww.oqp.med.va.gov/ programs/pm/pmReports.aspx; accessed 31 January 2011.
19. Sonnenberg A, Delco F, Inadomi JM. Cost-effectiveness of colonoscopy in screening for colorectal cancer. Ann Intern Med 2000; 133: 573-84.
20. Myers RE, Balshem AM, Wolf TA et al. Adherence to continuous screening for colorectal neoplasia. Med Care 1993; 31: 508-19.
21. O ' Malley AS, Forrest CB, Mandelblatt J. Adherence of low-income women to cancer screening recommendations. J Gen Intern Med 2002; 17: 144-54.
22. Subramanian S, Klosterman M, Amonkar MM et al. Adherence with colorectal cancer screening guidelines: a review. Prev Med 2004; 38: 536-50. (Pubitemid 38452879)
23. Th omas W, White CM, Mah J et al. Longitudinal compliance with annual screening for fecal occult blood. Minnesota Colon Cancer Control Study. Am J Epidemiol 1995; 142: 176-82.
24. Cooper GS, Koroukian SM. Geographic variation among Medicare beneficiaries in the use of colorectal carcinoma screening procedures. Am J Gastroenterol 2004; 99: 1544-50. (Pubitemid 39180105)
25. Ashton CM, Petersen NJ, Souchek J et al. Geographic variations in utilization rates in Veterans Affairs hospitals and clinics. N Engl J Med 1999; 340: 32-9. (Pubitemid 29024682)
26. Keyhani S, Ross JS, Hebert P et al. Use of preventive care by elderly male veterans receiving care through the Veterans Health Administration, Medicare fee-for-service, and Medicare HMO plans. Am J Public Health 2007; 97: 2179-85. (Pubitemid 351194695)
27. Borowsky SJ, Cowper DC. Dual use of VA and non-VA primary care. J Gen Intern Med 1999; 14: 274-80. (Pubitemid 29226672)
28. Walter LC, Davidowitz NP, Heineken PA et al. Pitfalls of converting practice guidelines into quality measures: lessons learned from a VA performance measure. JAMA 2004; 291: 2466-70. (Pubitemid 38669190)
29. Fisher DA, Galanko J, Dudley TK et al. Impact of comorbidity on colorectal cancer screening in the veterans healthcare system. Clin Gastroenterol Hepatol 2007; 5: 991-6. (Pubitemid 47127025)